Brief: Pharnext FY Net Loss At 21.5 Million Euros
April 27 (Reuters) - PHARNEXT SA PHARN.PA :
* REPORTS FINANCIAL RESULTS FOR YEAR-END 2020
* FY NET LOSS -21.5 MILLION EUR
* CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 11.1MILLION AT
DECEMBER 31, 2020 VERSUS EUR 16.2MILLION AT YEAR-END 2019
Source text for Eikon: ID:nEQ5YxYHLa
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development